ipamorelin pill form in cjc 1295 CJC-1295 (No DAC) 5mg, Ipamorelin 5mg (Blend) Ipamorelin 10mg CJC-1295 + Ipamorelin Peptide |

Take 1 sachet daily 2

We also recommend using our MET Beauty Face Soap as a daily facial cleanser

Nasal Spray Safety Profile Common Side Effects (Generally Mild): Temporary nasal dryness or irritation Mild burning sensation upon administration Occasional sneezing or nasal discharge Altered taste sensation (rare) Precautions : Avoid use with active nasal infections Monitor for signs of chronic irritation Ensure proper storage (some formulations require refrigeration) Use clean administration technique to prevent contamination Discontinue if persistent discomfort develops Contraindications : Severe nasal structural abnormalities Chronic nosebleeds or bleeding disorders Recent nasal surgery (wait 4-6 weeks) Active upper respiratory infections Oral Capsule Safety Profile Common Side Effects (Generally Mild): Mild gastrointestinal discomfort Temporary nausea (especially on empty stomach) Changes in bowel patterns Headache (uncommon) Precautions : Take with adequate water to ensure capsule dissolution Monitor for digestive changes Consider taking with small amount of food if nausea occurs Store in cool, dry location away from moisture Check expiration dates regularly Contraindications : Active gastrointestinal bleeding Severe inflammatory bowel disease (without medical supervision) Known peptide allergies Pregnancy and breastfeeding (insufficient safety data) General Safety Considerations Both delivery methods share common safety principles: Start Low, Go Slow : Begin with minimum effective doses and increase gradually Quality Matters : Source from reputable peptide suppliers with third-party testing Monitor Response : Track both benefits and any adverse reactions Cycle Appropriately : Most protocols recommend 4-8 week cycles with breaks Professional Guidance : Consult knowledgeable practitioners for personalized protocols Important Note : BPC-157 remains a research compound in many jurisdictions

You can also stay in touch at facebook.com/grayspharmacy

Every batch is subjected to High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis

Numerous NADs have transitioned from bench to bedside and have successfully been approved for clinical trials (Fig